Table 3.
Clinical and metadata of the Omicron and Delta infected patients.
| Variables, N (%) | Omicron | Delta |
|---|---|---|
| Total | 1119 | 908 |
| Collection range | 11/25/2021 to 12/31/21 | 11/22/21 to 12/31/21 |
| Fully Vaccinated (No booster) | 704 (62.9%) | 325 (35.8%) |
| Booster | 183 (16.4%) | 63 (6.9%) |
| Partially vaccinated | 35 (3.1%) | 22 (2.4%) |
| Symptomatic | 1036 (92.6%) | 836 (92.1%) |
| Gender | ||
| Female | 728 (65.1%) | 499 (55.0%) |
| Male | 391 (34.9%) | 409 (45.0%) |
| Age | ||
| median (IQR) | 32 (22-46) | 35 (17-55) |
| 0-44 | 809 (72.3%) | 577 (63.6%) |
| 45-64 | 255 (22.8%) | 215 (23.7%) |
| 65+ | 55 (4.9%) | 116 (12.8%) |
| Race/Ethnicity† | ||
| White | 360 (32.1%) | 381 (41.9%) |
| Black | 531 (47.4%) | 345 (37.9%) |
| Hispanic | 87 (7.8%) | 93 (10.2%) |
| Other | 143 (12.8%) | 91 (10.0%) |
| Comorbidities | ||
| Hypertension | 242 (21.6%) | 283 (31.2%) |
| Pregnancy | 84 (7.5%) | 53 (5.8%) |
| Lung Disease | 225 (20.1%) | 205 (22.6%) |
| Kidney Disease | 69 (6.2%) | 126 (13.9%) |
| Immunosuppression | 121 (10.8%) | 156 (17.2%) |
| Diabetes | 106 (9.5%) | 138 (15.2%) |
| Heart Failure | 29 (2.6%) | 62 (6.8%) |
| Atrial Fibrilation | 17 (1.5%) | 46 (5.1%) |
| Smoker | 115 (10.3%) | 142 (15.6%) |
| Cerebrovascular Disease | 46 (4.1%) | 69 (7.6%) |
| Cancer | 251 (22.4%) | 208 (22.9%) |
| Coronary Artery Disease | 85 (7.6%) | 151 (16.6%) |
| Outcome | ||
| COVID Related Admission* | 39 (3.5%) | 140 (15.4%) |
| ICU Level Care | 10 (0.9%) | 41 (4.5%) |
| COVID related Death | 3 (0.3%) | 21 (2.3%) |
| CT, N, (avg [StDev]) | 372 (18.7 [ 4.7]) | 640 (18.8 [ 4.9]) |
⁎
Patients admitted without symptoms or whose primary reason for admission was not COVID were not counted as a COVID-related admission
†
Race/Ethnicity separates out Hispanic as a separate group due to the higher noted incidence in this community.